Tekla Life Sciences Investors Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.57 | $1.57 | $1.57 |
| Q2 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 1 | $1.54 | $1.54 | $1.54 |
Tekla Life Sciences Investors Earnings Date And Information
Tekla Life Sciences Investors last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 1.03 M for the quarter and had revenue of 23.52 M for the year. Tekla Life Sciences Investors has generated $1 earnings per share over the last year ($0.83 diluted earnings per share) and currently has a price-to-earnings ratio of 9.75. Tekla Life Sciences Investors has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, December 9th, 2024 based on prior year's report dates.
Tekla Life Sciences Investors Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/29/2024 | Q2 2024 | $0.92 | $1.03 M | $1.03 M | ||
| 12/30/2023 | Q1 2024 | $0.92 | $1.03 M | |||
| 09/28/2023 | Q4 2023 | -$0.43 | $29.56 M | |||
| 03/30/2023 | Q2 2023 | $1.29 | $9.82 M | |||
| 12/30/2022 | Q1 2023 | $0.64 | $964,636 | |||
| 09/29/2022 | Q4 2022 | -$1.10 | $21.69 M | |||
| 06/29/2022 | Q3 2022 | -$0.55 | $792 | |||
| 03/30/2022 | Q2 2022 | -$3.03 | $10.17 M | |||
| 12/30/2021 | Q1 2022 | -$1.52 | $718 | |||
| 09/29/2021 | Q4 2021 | $1.34 | $15.98 M | |||
| 06/29/2021 | Q3 2021 | $0.67 | $589 | |||
| 03/30/2021 | Q2 2021 | $1.30 | $29.03 M | |||
| 12/30/2020 | Q1 2021 | $0.65 | $554 | |||
| 09/29/2020 | Q4 2020 | $3.91 | $16.50 M | |||
| 06/29/2020 | Q3 2020 | $1.94 | $606 | |||
| 03/30/2020 | Q2 2020 | $1.29 | $22.57 M | |||
| 12/30/2019 | Q1 2020 | $0.64 | $1,090 | |||
| 09/29/2019 | Q4 2019 | -$1.35 | $25.56 M | |||
| 06/29/2019 | Q3 2019 | -$0.68 | $657 | |||
| 03/31/2019 | Q2 2019 | -$0.00 | $563 |
Tekla Life Sciences Investors Earnings: Frequently Asked Questions
-
When is Tekla Life Sciences Investors's earnings date?
Tekla Life Sciences Investors has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, December 9th, 2024 based off last year's report dates.
-
How can I listen to Tekla Life Sciences Investors's earnings conference call?
The conference call for Tekla Life Sciences Investors's latest earnings report can be listened to online.
-
How can I read Tekla Life Sciences Investors's conference call transcript?
The conference call transcript for Tekla Life Sciences Investors's latest earnings report can be read online.
-
How much revenue does Tekla Life Sciences Investors generate each year?
Tekla Life Sciences Investors (:HQL) has a recorded annual revenue of $23.52 M.
-
How much profit does Tekla Life Sciences Investors generate each year?
Tekla Life Sciences Investors (:HQL) has a recorded net income of $23.52 M. Tekla Life Sciences Investors has generated $0.83 earnings per share over the last four quarters.
-
What is Tekla Life Sciences Investors's price-to-earnings ratio?
Tekla Life Sciences Investors (:HQL) has a price-to-earnings ratio of 9.75 and price/earnings-to-growth ratio is 0.2.
